Neuroprotective effect of tauroursodeoxycholic acid on n-methyl-daspartate-induced retinal ganglion cell degeneration

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Gómez Vicente, Violeta ^a   Lax, Pedro ^a   Fernández Sánchez, Laura ^a   Rondón, Netxibeth ^a   Esquiva, Gema ^a   Germain, Francisco ^b   De La Villa, Pedro ^b   Cuenca, Nicolás ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; TAUROURSODEOXYCHOLIC ACID; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT; TAUROCHENODEOXYCHOLIC ACID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFICACY; ELECTRORETINOGRAM; IN VIVO STUDY; NEUROPROTECTION; NONHUMAN; OSCILLATORY POTENTIAL; RAT; RETINA DEGENERATION; RETINA GANGLION CELL; ANIMAL; DRUG EFFECTS; ELECTRORETINOGRAPHY; OPTIC NERVE; PROCEDURES; RETINA; RETINAL DEGENERATION; SPRAGUE DAWLEY RAT;

ANIMALS; ELECTRORETINOGRAPHY; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; OPTIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL DEGENERATION; RETINAL GANGLION CELLS; TAUROCHENODEOXYCHOLIC ACID;

EID: 84945922080     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137826     Document Type: Article

References (49)

1. Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586: 4401-4408. doi: 10.1113/jphysiol.2008.156695
2. Ghaffarieh A, Levin LA (2012) Optic nerve disease and axon pathophysiology. Int Rev Neurobiol 105: 1-17. doi: 10.1016/B978-0-12-398309-1.00002-0
3. You Y, Gupta VK, Li JC, Klistorner A, Graham SL (2013) Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss. Rev Neurosci 24: 301-321. doi: 10.1515/revneuro-2013-0003
4. Farah MH (2006) Neurogenesis and cell death in the ganglion cell layer of vertebrate retina. Brain Res Rev 52: 264-274
5. Boatright JH, Moring AG, McElroy C, Phillips MJ, Do VT, Chang B, et al. (2006) Tool from ancient pharmacopoeia prevents vision loss. Mol Vis 12: 1706-1714
6. Phillips MJ, Walker TA, Choi HY, Faulkner AE, Kim MK, Sidney SS, et al. (2008) Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30. Invest Ophthalmol Vis Sci 49: 2148-2155. doi: 10.1167/iovs.07-1012
7. Oveson BC, Iwase T, Hackett SF, Lee SY, Usui S, Sedlak TW, et al. (2011) Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. J Neurochem 116: 144-153. doi: 10.1111/j.1471-4159.2010.07092.x
8. Fernandez-Sanchez L, Lax P, Pinilla I, Martin-Nieto J, Cuenca N (2011) Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. Invest Ophthalmol Vis Sci 52: 4998-5008. doi: 10.1167/iovs.11-7496
9. Drack AV, Dumitrescu AV, Bhattarai S, Gratie D, Stone EM, Mullins R, et al. (2012) TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice. Invest Ophthalmol Vis Sci 53: 100-106. doi: 10.1167/iovs.11-8544
10. Mantopoulos D, Murakami Y, Comander J, Thanos A, Roh M, Miller JW, et al. (2011) Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment. PLoS One 6: e24245. doi: 10.1371/journal.pone.0024245
11. Zhang T, Baehr W, Fu Y (2012) Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis. Invest Ophthalmol Vis Sci 53: 3349-3356. doi: 10.1167/iovs.12-9851
12. Boatright JH, Boyd AP, Garcia-Valenzuela E (2005) Effect of tauroursodeoxycholic acid on mouse retinal ganglion cell degeneration following optic nerve transection. Invest Ophthalmol Vis Sci 46.
13. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW (2006) Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 7: 66
14. Fernandez-Sanchez L, de Sevilla Muller LP, Brecha NC, Cuenca N (2014) Loss of outer retinal neurons and circuitry alterations in the DBA/2J mouse. Invest Ophthalmol Vis Sci 55: 6059-6072. doi: 10.1167/iovs.14-14421
15. Perez de Lara MJ, Santano C, Guzman-Aranguez A, Valiente-Soriano FJ, Aviles-Trigueros M, Vidal-Sanz M, et al. (2014) Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma. Exp Eye Res 122: 40-49. doi: 10.1016/j.exer.2014.02.022
16. Siliprandi R, Canella R, Carmignoto G, Schiavo N, Zanellato A, Zanoni R, et al. (1992) N-methyl-Daspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci 8: 567-573. PMID: 1586655
17. Sucher NJ, Lipton SA, Dreyer EB (1997) Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 37: 3483-3493
18. Lam TT, Abler AS, Kwong JM, Tso MO (1999) N-methyl-D-Aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 40: 2391-2397
19. Li Y, Schlamp CL, Nickells RW (1999) Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci 40: 1004-1008
20. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364: 535-537
21. Schinder AF, Olson EC, Spitzer NC, Montal M (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 16: 6125-6133
22. Ferreira IL, Duarte CB, Carvalho AP (1996) Ca2+ influx through glutamate receptor-Associated channels in retina cells correlates with neuronal cell death. Eur J Pharmacol 302: 153-162.
23. Saszik SM, Robson JG, Frishman LJ (2002) The scotopic threshold response of the dark-Adapted electroretinogram of the mouse. J Physiol 543: 899-916
24. Bui BV, Fortune B (2004) Ganglion cell contributions to the rat full-field electroretinogram. J Physiol 555: 153-173
25. Alarcon-Martinez L, de la Villa P, Aviles-Trigueros M, Blanco R, Villegas-Perez MP, Vidal-Sanz M (2009) Short and long term axotomy-induced ERG changes in albino and pigmented rats. Mol Vis 15: 2373-2383
26. Germain F, Istillarte M, Gomez-Vicente V, Perez-Rico C, de la Villa P (2013) Electroretinographical and histological study of mouse retina after optic nerve section: a comparison between wild-Type and retinal degeneration 1 mice. Clin Experiment Ophthalmol 41: 593-602. doi: 10.1111/ceo.12046
27. Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17: 485-521. PMID: 9777648
28. Korol S, Leuenberger PM, Englert U, Babel J (1975) In vivo effects of glycine on retinal ultrastructure and averaged electroretinogram. Brain Res 97: 235-251
29. Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-Lopez L, Canovas-Martinez I, Salinas-Navarro M, et al. (2009) Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 50: 3860-3868. doi: 10.1167/iovs.08-3267
30. Kwong JM, Quan A, Kyung H, Piri N, Caprioli J (2011) Quantitative analysis of retinal ganglion cell survival with Rbpms immunolabeling in animal models of optic neuropathies. Invest Ophthalmol Vis Sci 52: 9694-9702. doi: 10.1167/iovs.11-7869
31. Rodriguez AR, de Sevilla Muller LP, Brecha NC (2014) The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol 522: 1411-1443. doi: 10.1002/cne. 23521
32. Salinas-Navarro M, Jimenez-Lopez M, Valiente-Soriano FJ, Alarcon-Martinez L, Aviles-Trigueros M, Mayor S, et al. (2009) Retinal ganglion cell population in adult albino and pigmented mice: a computerized analysis of the entire population and its spatial distribution. Vision Res 49: 637-647. doi: 10.1016/j.visres.2009.01.010
33. Pascolini D, Mariotti SP (2012) Global estimates of visual impairment: 2010. Br J Ophthalmol 96: 614-618. doi: 10.1136/bjophthalmol-2011-300539
34. Fletcher EL, Hack I, Brandstatter JH, Wassle H (2000) Synaptic localization of NMDA receptor subunits in the rat retina. J Comp Neurol 420: 98-112
35. Kalloniatis M, Sun D, Foster L, Haverkamp S, Wassle H (2004) Localization of NMDA receptor subunits and mapping NMDA drive within the mammalian retina. Vis Neurosci 21: 587-597
36. Ohno Y, Nakanishi T, Umigai N, Tsuruma K, Shimazawa M, Hara H (2012) Oral administration of crocetin prevents inner retinal damage induced by N-methyl-D-Aspartate in mice. Eur J Pharmacol 690: 84-89. doi: 10.1016/j.ejphar.2012.06.035
37. Cheng H, Ding Y, Yu R, Chen J, Wu C (2014) Neuroprotection of a novel cyclopeptide CHSDGIC from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosis. PLoS One 9: e108090. doi: 10.1371/journal.pone.0108090
38. Zheng S, Yang H, Chen Z, Zheng C, Lei C, Lei B (2015) Activation of liver X receptor protects inner retinal damage induced by N-methyl-D-Aspartate. Invest Ophthalmol Vis Sci 56: 1168-1180. doi: 10. 1167/iovs.14-15612
39. Yamashita H, Yamada-Nakayama C, Sugihara K, Tsuji S, Sakurai T, Ban Y, et al. (2011) Functional and morphological effects of beta-estradiol in eyes with N-methyl-D-Aspartate-induced retinal neurotoxicity in rats. Exp Eye Res 93: 75-81. doi: 10.1016/j.exer.2011.04.006
40. Reyes RC, Brennan AM, Shen Y, Baldwin Y, Swanson RA (2012) Activation of neuronal NMDA receptors induces superoxide-mediated oxidative stress in neighboring neurons and astrocytes. J Neurosci 32: 12973-12978. doi: 10.1523/JNEUROSCI.1597-12.2012
41. Nakazawa T, Takahashi H, Nishijima K, Shimura M, Fuse N, Tamai M, et al. (2007) Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. J Neurochem 100: 1018-1031
42. El-Azab MF, Baldowski BR, Mysona BA, Shanab AY, Mohamed IN, Abdelsaid MA, et al. (2014) Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury. Br J Pharmacol 171: 1299-1313. doi: 10.1111/bph.12535
43. Seki M, Lipton SA (2008) Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog Brain Res 173: 495-510. doi: 10.1016/S0079-6123(08)01134-5
44. Baxter PS, Bell KF, Hasel P, Kaindl AM, Fricker M, Thomson D, et al. (2015) Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system. Nat Commun 6: 6761. doi: 10.1038/ncomms7761
45. Xie Q, Khaoustov VI, Chung CC, Sohn J, Krishnan B, Lewis DE, et al. (2002) Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 36: 592-601
46. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, et al. (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563-1573
47. Rodrigues CM, Sola S, Sharpe JC, Moura JJ, Steer CJ (2003) Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry 42: 3070-3080
48. Noailles A, Fernandez-Sanchez L, Lax P, Cuenca N (2014) Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects. J Neuroinflammation 11: 186. doi: 10.1186/s12974-014-0186-3
49. Yanguas-Casas N, Barreda-Manso MA, Nieto-Sampedro M, Romero-Ramirez L (2014) Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. J Neuroinflammation 11: 50. doi: 10.1186/1742-2094-11-50